ATE147978T1 - Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit - Google Patents
Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheitInfo
- Publication number
- ATE147978T1 ATE147978T1 AT93909326T AT93909326T ATE147978T1 AT E147978 T1 ATE147978 T1 AT E147978T1 AT 93909326 T AT93909326 T AT 93909326T AT 93909326 T AT93909326 T AT 93909326T AT E147978 T1 ATE147978 T1 AT E147978T1
- Authority
- AT
- Austria
- Prior art keywords
- fluoroallylamine
- fluorophenethyl
- alzheimer
- disease
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88867192A | 1992-05-27 | 1992-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE147978T1 true ATE147978T1 (de) | 1997-02-15 |
Family
ID=25393634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93909326T ATE147978T1 (de) | 1992-05-27 | 1993-04-14 | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0642338B1 (de) |
JP (1) | JPH07507299A (de) |
KR (1) | KR950701518A (de) |
AT (1) | ATE147978T1 (de) |
AU (1) | AU672401B2 (de) |
CA (1) | CA2135752C (de) |
DE (1) | DE69307702T2 (de) |
DK (1) | DK0642338T3 (de) |
ES (1) | ES2101311T3 (de) |
GR (1) | GR3022608T3 (de) |
HU (1) | HUT72316A (de) |
MX (1) | MX9303074A (de) |
NO (1) | NO944524L (de) |
WO (1) | WO1993024120A1 (de) |
ZA (1) | ZA933567B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09505276A (ja) * | 1993-09-24 | 1997-05-27 | メレルファーマスーティカルズ インコーポレイテッド | (E)−2−(p−フルオロフェネチル)−3−フルオロアリルアミンを含有するトランスダーマルデバイス、およびアルツハイマー病の処置に於けるその使用方法 |
US5488188A (en) * | 1994-09-29 | 1996-01-30 | Merrell Dow Pharmaceuticals Inc. | Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof |
US5599986A (en) * | 1994-09-29 | 1997-02-04 | Hoechst Marion Roussel Inc. | Process for the preparation of alkali metal salts of diformylamide |
EP2004166A2 (de) * | 2006-03-31 | 2008-12-24 | La Jolla Pharmaceutical Company | Inhibitoren der semicarbazid-sensitiven aminoxidase (ssao) und vap-1-vermittelten adhäsion zur behandlung und prävention von erkrankungen |
EP1870097A1 (de) * | 2006-06-15 | 2007-12-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamidederivate zur Behandlung von kognitiven Störungen |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR243493A1 (es) * | 1987-06-16 | 1993-08-31 | Merrell Dow Pharma | Procedimiento para preparar (e)-2-(p-fluorfenetil)-3-fluoralilamina y sus sales farmaceuticamente aceptables, util como inhibidor de mao-b irreversible y activado por enzimas. |
-
1993
- 1993-04-14 EP EP93909326A patent/EP0642338B1/de not_active Expired - Lifetime
- 1993-04-14 WO PCT/US1993/003522 patent/WO1993024120A1/en active IP Right Grant
- 1993-04-14 HU HU9403384A patent/HUT72316A/hu unknown
- 1993-04-14 AT AT93909326T patent/ATE147978T1/de active
- 1993-04-14 JP JP6500520A patent/JPH07507299A/ja active Pending
- 1993-04-14 AU AU39782/93A patent/AU672401B2/en not_active Ceased
- 1993-04-14 CA CA002135752A patent/CA2135752C/en not_active Expired - Fee Related
- 1993-04-14 ES ES93909326T patent/ES2101311T3/es not_active Expired - Lifetime
- 1993-04-14 KR KR1019940704236A patent/KR950701518A/ko not_active Application Discontinuation
- 1993-04-14 DE DE69307702T patent/DE69307702T2/de not_active Expired - Fee Related
- 1993-04-14 DK DK93909326.6T patent/DK0642338T3/da active
- 1993-05-21 ZA ZA933567A patent/ZA933567B/xx unknown
- 1993-05-26 MX MX9303074A patent/MX9303074A/es not_active IP Right Cessation
-
1994
- 1994-11-25 NO NO944524A patent/NO944524L/no not_active Application Discontinuation
-
1997
- 1997-02-19 GR GR970400294T patent/GR3022608T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0642338T3 (da) | 1997-02-10 |
CA2135752C (en) | 1998-07-14 |
EP0642338B1 (de) | 1997-01-22 |
DE69307702T2 (de) | 1997-05-28 |
AU672401B2 (en) | 1996-10-03 |
CA2135752A1 (en) | 1993-12-09 |
AU3978293A (en) | 1993-12-30 |
EP0642338A1 (de) | 1995-03-15 |
NO944524D0 (no) | 1994-11-25 |
WO1993024120A1 (en) | 1993-12-09 |
NO944524L (no) | 1994-11-25 |
HUT72316A (en) | 1996-04-29 |
ZA933567B (en) | 1993-12-13 |
GR3022608T3 (en) | 1997-05-31 |
HU9403384D0 (en) | 1995-02-28 |
MX9303074A (es) | 1994-01-31 |
KR950701518A (ko) | 1995-04-28 |
JPH07507299A (ja) | 1995-08-10 |
DE69307702D1 (de) | 1997-03-06 |
ES2101311T3 (es) | 1997-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69322957D1 (de) | L - Deprenyl zur Behandlung von makulärer Degeneration | |
DE69230046T2 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
EP0735870A4 (de) | Verwendung von phospholipase-a2-inhibitoren zur behandlung der alzheimer-krankheit | |
ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
DE4394931T1 (de) | Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen | |
ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
ATE147978T1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
MY104521A (en) | Treatment of depression. | |
RU94011321A (ru) | Способ профилактики и лечения заболеваний кожи | |
DE69800906D1 (de) | Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie | |
NO961180L (no) | Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom | |
DE69421705D1 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen | |
KR930703003A (ko) | 피부질환치료용 제약 조성물 |